Cost-Effectiveness of Nivolumab-Ipilimumab Combination Therapy Compared with Monotherapy for First-Line Treatment of Metastatic Melanoma in the United States

BACKGROUND: The approval of new immunotherapies has dramatically changed the treatment landscape of metastatic melanoma. These survival gains come with trade-offs in side effects and costs, as well as important considerations for third-party payer systems, physicians, and patients. OBJECTIVE: To dev...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Manag Care Spec Pharm
Main Authors: Oh, Anna, Tran, Dang M., McDowell, Leann C., Keyvani, Dor, Barcelon, Jay Andrew, Merino, Oscar, Wilson, Leslie
Format: Artigo
Sprog:Inglês
Udgivet: Academy of Managed Care Pharmacy 2017
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5960988/
https://ncbi.nlm.nih.gov/pubmed/28530525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18553/jmcp.2017.23.6.653
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker